Publications
- Emicizumab - a new direction of treatment in patients with haemophilia and inhibitor2019 | Second Faculty of Medicine
- The Role of Plasma Procalcitonin and Other Inflammatory Markers as Identifiers of Bacterial Infections in Children with Solid Tumor2005 | Second Faculty of Medicine
- Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)2023 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 20092023 | Second Faculty of Medicine
- Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia2023 | Second Faculty of Medicine
- Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres2023 | Second Faculty of Medicine
- Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia2022 | Second Faculty of Medicine
- First experience of a hemophilia monitoring platform: florio HAEMO2022 | Second Faculty of Medicine
- Severe congenital bleeding disorders manifesting in the neonatal period - case reports2022 | Second Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with haemophilia, 3rd edition, year 20212021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...